| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/02770903.2010.485666 |
| P8608 | Fatcat ID | release_vbdsqnfxqvafjjlr22fmg3zncm |
| P698 | PubMed publication ID | 20653496 |
| P2093 | author name string | Shimon Pollack | |
| Eduardo Shahar | |||
| Gamal Hassoun | |||
| Eynat Kedem | |||
| P2860 | cites work | Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir | Q34136761 |
| Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole | Q35638031 | ||
| Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature | Q37155805 | ||
| Influence of antiretroviral drugs on the pharmacokinetics of prednisolone in HIV-infected individuals | Q37160501 | ||
| Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature. | Q37409009 | ||
| Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids | Q40949693 | ||
| Comparison of inhaled corticosteroids | Q41718750 | ||
| Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases | Q45310703 | ||
| Drug interactions between inhaled corticosteroids and enzymatic inhibitors. | Q46034036 | ||
| Prednisolone pharmacokinetics in the presence and absence of ritonavir after oral prednisone administration to healthy volunteers | Q46801339 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ritonavir | Q422618 |
| Cushing's syndrome | Q219102 | ||
| patient | Q181600 | ||
| asthma | Q35869 | ||
| P304 | page(s) | 830-831 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | Journal of Asthma | Q2603603 |
| P1476 | title | Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient | |
| P478 | volume | 47 |
| Q92740864 | A prospective evaluation on the interaction of fluconazole and voriconazole on serum concentrations of budesonide in patients treated for gastrointestinal GVHD |
| Q41996857 | A review of drug-drug interactions in older HIV-infected patients |
| Q41464320 | Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol |
| Q35225926 | Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy |
| Q37378110 | Antiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for management |
| Q35803482 | Asthma diagnosis and airway bronchodilator response in HIV-infected patients |
| Q42238841 | Avascular necrosis in a HIV patient receiving ritonavir and inhaled fluticasone |
| Q36338883 | Cushing syndrome due to ritonavir-fluticasone interaction |
| Q48424453 | Cushing's syndrome with adrenal suppression induced by inhaled budesonide due to a ritonavir drug interaction in a woman with HIV infection |
| Q30358406 | Diagnosis and treatment of HIV-associated manifestations in otolaryngology |
| Q37730342 | Disease drivers of aging |
| Q90641384 | Exogenous steroid-induced hypoadrenalism in a person living with HIV caused by a drug-drug interaction between cobicistat and intrabursal triamcinolone |
| Q36950536 | Human immunodeficiency virus-associated obstructive lung diseases |
| Q40539589 | Iatrogenic Cushing Syndrome from Interaction Between Ritonavir and Oral Budesonide During Direct Acting Antiviral Hepatitis C Therapy |
| Q45072083 | Iatrogenic Cushing Syndrome in a 47-Year-Old HIV-Positive Woman on Ritonavir and Inhaled Budesonide |
| Q35995856 | Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone |
| Q38971196 | Iatrogenic Cushing's syndrome due to drug interaction between glucocorticoids and the ritonavir or cobicistat containing HIV therapies. |
| Q38438991 | Iatrogenic cushing syndrome secondary to a probable interaction between voriconazole and budesonide |
| Q37962449 | Important Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs. |
| Q35056151 | Inhalational Steroids and Iatrogenic Cushing's Syndrome |
| Q37135137 | Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management |
| Q38429711 | Linear growth arrest without weight gain due to overuse of topical clobetasol |
| Q34564288 | Noninfectious pulmonary complications of human immunodeficiency virus infection |
| Q42360048 | Rebound adrenal insufficiency after withdrawal of ritonavir in a 65-year-old man using inhaled budesonide |
| Q51558627 | Respiratory co-morbidities in people with HIV. |
| Q98829978 | What we have to know about corticosteroids use during Sars-Cov-2 infection |
Search more.